On the Brink

Click to view the PDF file: Important Events in Stem Cell Research Graphic: Leza Berardone As the Bush administration stood on the verge this month of announcing a decision on whether the federal government will fund embryonic stem cell (ESC) research, the scientists involved braced themselves for the worst and continued planning for ways to move ahead. An issue that is politically, ethically, and religiously loaded, this tempest, like the issues of RU-486 and abortion before it, has galvani

Written byTed Agres
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

"There are a lot of new studies about sources from adult stem cells, from human fat cells, and placenta," says Tommy Thompson, secretary of Health and Human Services (HHS), "It's not just embryonic cells" that may provide stem cell lines for research. A decision, he says, could be reached as soon as next week. A meeting slated for April 25 to review submitted proposals was quietly and indefinitely postponed.

The administration's presumed position makes no sense to many scientists, including 80 Nobel laureates and 115 college and university leaders who have lobbied, via position papers, for federal funds to allow embryonic research to begin. The plasticity of these cells, as compared to those derived from other sources, is preferable. "For the [United States] not to fund this research will lead to an exodus of talent to other countries and will eventually hurt our biotech and pharmaceutical industries, with potentially disastrous ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies